Somewhat reduced staining intensity was observed for CF patients using mAbs 450, 570 and 24.1 but no statistical differences were observed between MFI of healthy controls and CF cells upon staining with CFTR-directed antibodies. This evidence concerns the gene CFTR and cystic fibrosis.